Phase II study of ceralasertib (AZD6738) in combination with durvalumab in patients with advanced gastric cancer.

Minsuk KwonGahyun KimRyul KimKyu-Tae KimSeung Tae KimSimon SmithPeter G S MortimerJung Yong HongArsene-Bienvenu LoembéItziar Irurzun-AranaLoumpiana KoulaiKyoung-Mee KimWon Ki KangEmma DeanWoong-Yang ParkJeeyun Lee

Published in: Journal for immunotherapy of cancer (2022)

NCT03780608.

Keyphrases

phase ii study
locally advanced
neoadjuvant chemotherapy
open label
rectal cancer
squamous cell carcinoma
placebo controlled
radiation therapy
randomized controlled trial
lymph node
study protocol